Medicine and Dentistry
Analysis
19%
Antibody
40%
Antigen
41%
Antigen Antibody Reaction
8%
Assay
87%
Child
8%
Coronavirinae
12%
Cost-Effectiveness Analysis
8%
COVID-19
48%
Cross Reaction
11%
Culture
8%
Diagnosis
22%
Disease
8%
Disinfection
8%
Enzyme Linked Immunosorbent Assay
25%
Epidemic
8%
Experience
25%
False Negative Result
6%
False Positive Result
6%
Follow up
8%
Gene
29%
Health Care
25%
Hospital
25%
Hygiene
8%
Immunogenicity
25%
Immunoglobulin A
25%
Immunoglobulin G
25%
Immunoglobulin M
6%
Immunoglobulin M Antibody
25%
Infection
12%
Injection
16%
Laboratory
52%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
8%
Messenger RNA
25%
Molecular Diagnosis
16%
mRNA Vaccine
8%
Pathogen
16%
Patient
30%
Quantitative Reverse Transcription Polymerase Chain Reaction
96%
Rapid Test
27%
Real-Time Polymerase Chain Reaction
25%
Screening
25%
Sensitivity and Specificity
6%
Serotype
25%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Shock (Circulatory)
6%
Smear
8%
Surveillance
25%
Vaccine
25%
Virus
20%
Biochemistry, Genetics and Molecular Biology
Antibody
43%
Clinical Trial
25%
Cross Reaction
15%
Development
25%
Dilution
6%
Dose
25%
Experience
25%
Extraction
25%
Health
25%
Immunogenicity
25%
Immunoglobulin G
25%
Immunoglobulin M
25%
Kinetics
37%
Messenger RNA
25%
Nested Gene
31%
Polymerase Chain Reaction
25%
Quantitative Technique
25%
Recognition
25%
RNA Sequence
6%
Sample
50%
SARS Coronavirus
100%
Time
6%
Turnaround Time
31%
Virus Nucleocapsid
6%
Volume
6%
Immunology and Microbiology
Aegle
7%
Antigen
37%
Antigen-Antibody Interaction
8%
COVID-19
16%
Cross-Reactivity
19%
Cycle Threshold
6%
ELISA
25%
Experience
25%
Gene
6%
Genome Sequencing
8%
Immunoassay
13%
Immunoglobulin G Antibody
53%
Immunoglobulin M
12%
Immunoglobulin M Antibody
50%
Kinetics
25%
Matrix-Assisted Laser Desorption-Ionization
8%
Monospecific Antibody
50%
Nail
6%
Recognition
25%
Respiratory Virus
16%
RNA Sequence
6%
Sample
58%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Time-of-Flight Mass Spectrometry
8%
Turnaround Time
25%
Virus Nucleocapsid
6%
Volume
6%